# US 2021/0340612 A1 · Process for cognate nucleotide detection in a nucleic acid sequencing workflow

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0340612 A1
- Document ID: US20210340612A1
- Status: Published application
- Kind: A1
- Application number: 17/190,894
- Filed: 2021-03-03
- Published: 2021-11-04
- Earliest claimed: 2017-01-20
- Assignees: Omniome, Inc.
- Applicants: Omniome, Inc.
- Inventors: Corey M. DAMBACHER; Joseph ROKICKI; Keunho AHN; Brittany Ann ROHRMAN; Michael NGUYEN; Kandaswamy VIJAYAN
- Web page: https://patentgrep.com/patent/US20210340612A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C07H 21/02: with ribosyl as saccharide radical
- C07H 21/04: with deoxyribosyl as saccharide radical
- C07H 99/00: Subject matter not provided for in other groups of this subclass
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12N 9/1241: {Nucleotidyltransferases (2.7.7)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Method and composition for identifying cognate nucleotides in a Sequencing By Binding™ procedure, wherein one or more labeled nucleotides are detected in ternary complexes but never incorporated. Labeled nucleotides can be incorporable nucleotides that contact preformed blocked primed template nucleic acids. Alternatively, labeled nucleotides are labeled non-incorporable nucleotides. Labeled nucleotides, including labeled non-incorporable nucleotides, can be detected in ternary complexes in the same reaction mixture that incorporates a reversible terminator nucleotide to create a blocked primed template nucleic acid. Detection of ternary complexes can take place in the presence of a catalytic metal ion.

## Claims

### Claim at position 1

-25. (canceled)

### Claim 26

A method of identifying cognate nucleotides for each of a plurality of nucleic acid features, each feature comprising a primed template nucleic acid molecule, said method comprising the steps of:
(a) preparing first stabilized ternary complexes at each of the plurality of nucleic acid features, each stabilized ternary complex comprising the primed template nucleic acid molecule at its respective nucleic acid feature, a reversible terminator nucleotide, and a polymerase;
(b) contacting the first stabilized ternary complexes from step (a) with a reagent comprising a catalytic metal ion, at least one distinguishably labeled incorporable nucleotide, and a polymerase, to produce a reaction mixture,
whereby the reversible terminator nucleotide incorporates into the primed template nucleic acid molecule to produce a blocked primed template nucleic acid molecule at each of the plurality of nucleic acid features, and
whereby there forms at each of the plurality of nucleic acid features a second stabilized ternary complex comprising the blocked primed template nucleic acid molecule and one of the distinguishably labeled incorporable nucleotides; and
(c) identifying cognate nucleotides for the primed template nucleic acid molecules at each of the plurality of nucleic acid features by detecting, in the reaction mixture, a label joined to the distinguishably labeled incorporable nucleotide of the second stabilized ternary complex.

### Claim at position 3

-32. (canceled)

### Claim 33 (depends on 26)

The method of claim 26, wherein the polymerase of step (b) is the same type of polymerase as in step (a).

### Claim 34 (depends on 26)

The method of claim 26, wherein the blocked primed template nucleic acid molecule of step (b) comprises a reversible terminator moiety at its 3′ terminus, and wherein the method further comprises the step of cleaving the reversible terminator moiety from the blocked primed template nucleic acid molecule to produce a 3′ terminus available for polymerization.

### Claim 35 (depends on 26)

The method of claim 26, wherein the catalytic metal ion in the second reaction mixture is selected from the group consisting of Mg2+ ion and Mn2+ ion.

### Claim 36 (depends on 26)

The method of claim 26, wherein the blocked primed template nucleic acid molecule of step (b) is immobilized to a solid support and wherein the solid support is contained within a flow cell.

### Claim 37 (depends on 36)

The method of claim 36, wherein each of the plurality of nucleic acid features is contained within the flow cell.

### Claim 38 (depends on 26)

The method of claim 26, wherein the label on the distinguishably labeled incorporable nucleotides is a distinguishable fluorescent label.

### Claim 39 (depends on 38)

The method of claim 38, wherein the distinguishable fluorescent label does not comprise an intercalating dye that changes fluorescence after contacting DNA.

### Claim 40 (depends on 38)

The method of claim 38, wherein the distinguishable fluorescent label is covalently attached to the incorporable nucleotide by a linker at a position on the nitrogenous base.

### Claim 41 (depends on 26)

The method of claim 26, further comprising the step of (d) preparing a second reaction mixture by contacting the second stabilized ternary complex with one or more wash reagents that destabilize ternary complexes and removes a reversible terminator moiety from the reversible terminator nucleotides on the blocked primed template nucleic acid molecules.

### Claim 42 (depends on 41)

The method of claim 41, wherein the primed template nucleic acid comprises a 3′ end and step (d) results in the 3′ end of the primed template nucleic acid made available for polymerization.

### Claim 43 (depends on 41)

The method of claim 41, wherein the method further involves repeating steps (a)-(d).

### Claim 44 (depends on 26)

The method of claim 26, further comprising, after step (c), the steps of:
(i) stripping the polymerase and the distinguishably labeled incorporable nucleotide of the second stabilized ternary complex from the blocked primed template nucleic acid molecule;
(ii) cleaving a reversible terminator moiety from the blocked primed template nucleic acid molecule to create a deblocked primed template nucleic acid molecule comprising a 3′ terminus available for polymerization; and
(iii) incorporating a reversible terminator into the deblocked primed template nucleic acid molecule.

### Claim 45 (depends on 26)

The method of claim 26, wherein the distinguishably labeled incorporable nucleotides in step (b) comprise at least two types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides.

### Claim 46 (depends on 26)

The method of claim 26, wherein the distinguishably labeled incorporable nucleotides in step (b) comprises at least three types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides.

### Claim 47 (depends on 26)

The method of claim 26, wherein the distinguishably labeled incorporable nucleotides in step (b) comprises four types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides.

### Claim 48 (depends on 41)

The method of claim 41, wherein step (b) is performed after a plurality of cycles of performing steps (b) and (c).

### Claim 49 (depends on 48)

The method of claim 48, wherein each of the plurality of cycles uses a different distinguishably labeled incorporable nucleotide.

### Claim 50 (depends on 26)

The method of claim 26, wherein none of the distinguishably labeled incorporable nucleotides of step (c) includes a reversible terminator moiety.

### Claim 51 (depends on 26)

The method of claim 26, wherein the reversible terminator nucleotide is unlabeled.
